Literature DB >> 12269393

Arthrospira maxima prevents the acute fatty liver induced by the administration of simvastatin, ethanol and a hypercholesterolemic diet to mice.

J L Blé-Castillo1, A Rodríguez-Hernández, R Miranda-Zamora, M A Juárez-Oropeza, J C Díaz-Zagoya.   

Abstract

An evident fatty liver, corroborated morphologically and chemically, was produced in CD-1 mice after five daily doses of simvastatin 75 mg/Kg body weight, a hypercholesterolemic diet and 20 percent ethanol in the drinking water. After treating the animals, they presented serum triacylglycerols levels five times higher than the control mice, total lipids, cholesterol and triacylglycerols in the liver were 2, 2 and 1.5 times higher, respectively, than in control animals. When Arthrospira maxima was given with diet two weeks prior the onset of fatty liver induction, there was a decrement of liver total lipids (40%), liver triacylglycerols (50%) and serum triacylglycerols (50%) compared to the animals with the same treatment but without Arthrospira maxima. In addition to the mentioned protective effect, the administration of this algae, produced a significant increase (45%) in serum high density lipoproteins. The mechanism for this protective effect was not established in these experiments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12269393     DOI: 10.1016/s0024-3205(02)01512-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  The effects of Spirulina on anemia and immune function in senior citizens.

Authors:  Carlo Selmi; Patrick S C Leung; Laura Fischer; Bruce German; Chen-Yen Yang; Thomas P Kenny; Gerry R Cysewski; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  Hypolipidemic, antioxidant, and antiinflammatory activities of microalgae Spirulina.

Authors:  Ruitang Deng; Te-Jin Chow
Journal:  Cardiovasc Ther       Date:  2010-08       Impact factor: 3.023

3.  Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series.

Authors:  Aldo Ferreira-Hermosillo; Patricia V Torres-Duran; Marco A Juarez-Oropeza
Journal:  J Med Case Rep       Date:  2010-04-07

4.  Exercise and spirulina control non-alcoholic hepatic steatosis and lipid profile in diabetic Wistar rats.

Authors:  Leandro P Moura; Guilherme M Puga; Wladimir R Beck; Inaian P Teixeira; Ana Carolina Ghezzi; Gláucio A Silva; Maria Alice R Mello
Journal:  Lipids Health Dis       Date:  2011-05-15       Impact factor: 3.876

5.  Effect of polycan, a β-glucan originating from Aureobasidium, on a high-fat diet-induced hyperlipemic hamster model.

Authors:  Mee-Kyoung Lim; Sae-Kwang Ku; Jae-Suk Choi; Joo-Wan Kim
Journal:  Exp Ther Med       Date:  2015-01-29       Impact factor: 2.447

6.  Consequences of AphanizomenonFlos-aquae(AFA) extract (Stemtech (TM) ) on metabolic profile of patients with type 2 diabetes.

Authors:  Maryam Sanaei; Mehdi Ebrahimi; Zahra Banazadeh; Gita Shafiee; Fatemeh Khatami; Zeinab Ahadi; Ramin Heshmat
Journal:  J Diabetes Metab Disord       Date:  2015-06-24

7.  Effect on supplementation of Spirulina maxima enriched with Cu on production performance, metabolical and physiological parameters in fattening pigs.

Authors:  A Saeid; K Chojnacka; M Korczyński; D Korniewicz; Z Dobrzański
Journal:  J Appl Phycol       Date:  2013-02-15       Impact factor: 3.215

8.  The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study.

Authors:  Elias E Mazokopakis; Maria G Papadomanolaki; Andreas A Fousteris; Dimitrios A Kotsiris; Ioannis M Lampadakis; Emmanuel S Ganotakis
Journal:  Ann Gastroenterol       Date:  2014

9.  Double-blind randomised controlled trial of the independent and synergistic effect of Spirulina maxima with exercise (ISESE) on general fitness, lipid profile and redox status in overweight and obese subjects: study protocol.

Authors:  Marco Antonio Hernández-Lepe; José Alberto López-Díaz; Laura Alejandra de la Rosa; Rosa Patricia Hernández-Torres; Abraham Wall-Medrano; Marco Antonio Juarez-Oropeza; José Pedraza-Chaverri; Rene Urquidez-Romero; Arnulfo Ramos-Jiménez
Journal:  BMJ Open       Date:  2017-06-23       Impact factor: 2.692

10.  Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report.

Authors:  Patricia V Torres-Duran; Aldo Ferreira-Hermosillo; Marco A Juarez-Oropeza
Journal:  Lipids Health Dis       Date:  2007-11-26       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.